Considering the unique role of ELK1 in activating gene transcription related to cancer progression, we conducted an in-depth evaluation of its value in endometrial carcinoma and confirmed that ELK1 enhanced GPX4 transcription, inhibited ferroptosis, and promoted cancer progression. This evidence concerns the gene GPX4 and endometrial carcinoma.